1. Kumano N, Ishikawa T, Koinumaru S, et al. Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57 BL/6 (B6) mice. Tohoku J Exp Med 1985;146:97–104.
2. Sato H, Iwaguchi T. Antitumor effect of a novel organogermanium compound, G-132, Jap J Cancer Chemother 1979;6:79–83.
3. Saiers JH, Slavik M, Stephens RL, Crawford ED. Therapy for advanced renal cell cancer with spirogermanium: a southwest oncology group study. Cancer Treat Rep 1987;71:207–8.
4. Falkson G, Falkson HC. Phase II trial of spirogermanium for treatment of advanced breast cancer. Cancer Treat Rep 1983;67:189–90.
5. Goodwin JW, Crowley J, Tranum B, et al. Phase II trial of spirogermanium in central nervous system tumors: a southwest oncology group study. Cancer Treat Rep 1987;71:99–100.